EDGAR Filing Documents for 0001104659-17-035028

Form 6-K - Report of foreign issuer [Rules 13a-16 and 15d-16]:

SEC Accession No. 0001104659-17-035028

Filing Date

2017-05-25

Accepted

2017-05-25 09:19:15

Documents

Period of Report

2017-05-25

Document Format Files

Seq	Description	Document	Type	Size
1	6-K	a17-14166_16k.htm	6-K	15925
2	EX-99.1	a17-14166_1ex99d1.htm	EX-99.1	6698
3	GRAPHIC	g141661mmi001.jpg	GRAPHIC	3085
	Complete submission text file	0001104659-17-035028.txt		28080

Mailing Address 900 NORTHBROOK DRIVE, SUITE 200 TREVOSE PA 19053

Business Address 900 NORTHBROOK DRIVE, SUITE 200 TREVOSE PA 19053 (610) 254-9200

Strongbridge Biopharma plc (Filer) CIK: 0001634432 (see all company filings)

IRS No.: 981130690 | State of Incorp.: L2
Type: 6-K | Act: 34 | File No.: 001-37569 | Film No.: 17868434
SIC: 2834 Pharmaceutical Preparations